CFD
Complement factor D
Also known as: ADN, CFAD_HUMAN, DF, PFD
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P00746
- Gene
- CFD
- Ensembl
- ENSG00000197766
- Chromosome
- 19
- Canonical length
- 253 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a member of the S1, or chymotrypsin, family of serine peptidases. This protease catalyzes the cleavage of factor B, the rate-limiting step of the alternative pathway of complement activation. This protein also functions as an adipokine, a cell signaling protein secreted by adipocytes, which regulates insulin secretion in mice. Mutations in this gene underlie complement factor D deficiency, which is associated with recurrent bacterial meningitis infections in human patients. Alternative splicing of this gene results in multiple transcript variants. At least one of these variants encodes a preproprotein that is proteolytically processed to generate the mature protease. [provided by RefSeq, Nov 2015]
Canonical amino-acid sequenceUniProt
253 residues, UniProt reviewed canonical sequence.
>P00746|CFD
1 MHSWERLAVL VLLGAAACAA PPRGRILGGR EAEAHARPYM ASVQLNGAHL CGGVLVAEQW
61 VLSAAHCLED AADGKVQVLL GAHSLSQPEP SKRLYDVLRA VPHPDSQPDT IDHDLLLLQL
121 SEKATLGPAV RPLPWQRVDR DVAPGTLCDV AGWGIVNHAG RRPDSLQHVL LPVLDRATCN
181 RRTHHDGAIT ERLMCAESNR RDSCKGDSGG PLVCGGVLEG VVTSGSRVCG NRKKPGIYTR
241 VASYAAWIDS VLALocalizationUniProt · AlphaFold · HPA
Whether an antibody against CFD can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 1,422 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 1,422 nTPM
- breast: 958 nTPM
- urinary bladder: 868 nTPM
- heart muscle: 839 nTPM
- vagina: 701 nTPM
- blood vessel: 630 nTPM
Single-cell type
- decidual stromal cells: 2,524 nCPM
- fibroblasts: 2,407 nCPM
- leydig cells: 1,762 nCPM
- prostatic club cells: 286 nCPM
- hepatic stellate cells: 239 nCPM
- kupffer cells: 205 nCPM
Immune cell
- basophil: 1,713 nTPM
- eosinophil: 675 nTPM
- neutrophil: 498 nTPM
- non-classical monocyte: 305 nTPM
- intermediate monocyte: 219 nTPM
- classical monocyte: 208 nTPM
Brain region
- white matter: 17 nTPM
- cerebellum: 15 nTPM
- cerebral cortex: 14 nTPM
- pons: 14 nTPM
- hypothalamus: 14 nTPM
- medulla oblongata: 13 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CFD.
Disease | AllUniProt
Conditions CFD is implicated in, by any mechanism.
- Complement factor D deficiency (CFDD) MIM:613912
Disease | GeneticClinVar
12 pathogenic / likely-pathogenic of 318 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Recurrent Neisseria infections due to factor D deficiency
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.68
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.63
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- complement activation
- complement activation, alternative pathway
- protein maturation
- proteolysis
- response to bacterium
- zymogen activation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CFD as an antibody target. Whether an autoantibody or antibody against CFD could matter depends on whether native CFD is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CFD is annotated as secreted, so native CFD circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label CFD as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...